A detailed history of Indiana Trust & Investment Management CO transactions in Amgen Inc stock. As of the latest transaction made, Indiana Trust & Investment Management CO holds 1,960 shares of AMGN stock, worth $618,458. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,960
Previous 1,960 -0.0%
Holding current value
$618,458
Previous $612,000 3.1%
% of portfolio
0.22%
Previous 0.23%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 07, 2023

SELL
$214.27 - $253.37 $13,927 - $16,469
-65 Reduced 3.21%
1,960 $435,000
Q1 2023

Apr 06, 2023

SELL
$225.79 - $275.2 $6,547 - $7,980
-29 Reduced 1.41%
2,025 $489,000
Q4 2022

Jan 09, 2023

SELL
$229.03 - $291.01 $3,435 - $4,365
-15 Reduced 0.72%
2,054 $539,000
Q4 2020

Jan 07, 2021

SELL
$216.38 - $257.67 $7,789 - $9,276
-36 Reduced 1.71%
2,069 $476,000
Q2 2020

Jul 14, 2020

SELL
$197.81 - $242.74 $4,945 - $6,068
-25 Reduced 1.17%
2,105 $496,000
Q1 2020

Apr 06, 2020

SELL
$182.24 - $241.7 $12,756 - $16,919
-70 Reduced 3.18%
2,130 $432,000
Q4 2019

Jan 13, 2020

SELL
$189.21 - $243.2 $14,190 - $18,240
-75 Reduced 3.3%
2,200 $530,000
Q2 2019

Jul 10, 2019

SELL
$166.7 - $195.41 $5,001 - $5,862
-30 Reduced 1.3%
2,275 $419,000
Q1 2019

Apr 08, 2019

SELL
$180.87 - $203.88 $289,392 - $326,208
-1,600 Reduced 40.97%
2,305 $438,000
Q4 2018

Jan 07, 2019

BUY
$178.4 - $208.25 $5,530 - $6,455
31 Added 0.8%
3,905 $760,000
Q3 2018

Oct 11, 2018

SELL
$185.29 - $208.89 $58,922 - $66,427
-318 Reduced 7.59%
3,874 $803,000
Q2 2018

Jul 06, 2018

SELL
$166.05 - $186.51 $830 - $932
-5 Reduced 0.12%
4,192 $774,000
Q1 2018

Apr 09, 2018

BUY
$169.43 - $198.0 $34,394 - $40,194
203 Added 5.08%
4,197 $716,000
Q4 2017

Jan 12, 2018

BUY
$168.79 - $188.59 $258,248 - $288,542
1,530 Added 62.09%
3,994 $695,000
Q3 2017

Oct 05, 2017

BUY
$167.29 - $191.0 $412,202 - $470,624
2,464
2,464 $459,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Indiana Trust & Investment Management CO Portfolio

Follow Indiana Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indiana Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Indiana Trust & Investment Management CO with notifications on news.